Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,420 | -1,599 | -7,121 | -5,924 | -4,095 |
| Depreciation Amortization | 260 | 141 | 618 | 464 | 307 |
| Accounts receivable | -7 | -53 | -8 | -10 | -5 |
| Accounts payable and accrued liabilities | -252 | 51 | 106 | 62 | -4 |
| Other Working Capital | -440 | -377 | -72 | 224 | 250 |
| Other Operating Activity | 362 | 430 | 1,682 | 1,119 | 799 |
| Operating Cash Flow | $-3,497 | $-1,407 | $-4,795 | $-4,065 | $-2,748 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25 | N/A | N/A | N/A | N/A |
| PPE Investments | 642 | 694 | -72 | -78 | -51 |
| Purchase Sale Intangibles | -411 | -114 | -370 | -222 | -145 |
| Other Investing Activity | -411 | -114 | -370 | -222 | -145 |
| Investing Cash Flow | $206 | $580 | $-442 | $-300 | $-196 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2 | -1 | -3 | -3 | -2 |
| Common Stock Issued | 3,963 | 852 | 4,454 | 3,649 | 3,303 |
| Financing Cash Flow | $3,961 | $851 | $4,451 | $3,646 | $3,301 |
| Exchange Rate Effect | 30 | 25 | -7 | -9 | -9 |
| Beginning Cash Position | 405 | 405 | 1,198 | 1,198 | 1,198 |
| End Cash Position | 1,105 | 454 | 405 | 470 | 1,546 |
| Net Cash Flow | $700 | $49 | $-793 | $-728 | $348 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,497 | -1,407 | -4,795 | -4,065 | -2,748 |
| Capital Expenditure | -37 | -8 | -112 | -94 | -67 |
| Free Cash Flow | -3,534 | -1,415 | -4,907 | -4,159 | -2,815 |